Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in ...

In this webinar, we demonstrate a use case for characterizing the health of starting donor material in cell therapy manufacturing using the Invitrogen™ Attune™ CytPix™ Flow Cytometer to monitor T-cell ...

Cytolight Red A549 target cells were seeded at 5K cells/well into a 96-well plate in 4Cell ® Nutri-T GMP medium topped up with FBS. Cells were permitted to adhere for 3 hours in a 37 °C, 5 % CO ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow cytometry-based panel for profiling CAR T cells that could be used to optimize their ...

An AI-enabled microfluidic cytometer could make flow cytometry more accessible, affordable and faster. A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA ...

Cells were expanded, tested, and cryopreserved. Flow cytometry was used to assess the immune characteristics of the CAR T cells and to check their persistence and function after infusion.

Fluorescence imaging tracked nanoparticle localization and persistence post-injection, while immunohistochemical analyses assessed T cell activation markers, including CD8 and PD-1, within the tumors.

Candid joins a number of high-profile companies that are making waves in the space. In January 2024, MSD acquired Harpoon in a $680m deal, which included Harpoon’s T cell engagers. One of the ...

JNJ-4496, formerly known as C-CAR039, is a dual-targeting CAR T designed to bind to both CD19 and CD20 antigens — two cell surface proteins commonly expressed on malignant B-cells.

Seattle Children’s Therapeutics BrainChild-03 Phase 1 clinical trial with SCRI-CARB7H3 (s), an autologous CAR T cell product designed to specifically target B7-H3 in CNS tumors. DIPG Registry.